The spectrum of Nocardia lung disease in cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015
Early eradication of pseudomonas aeruginosa (PA) in cystic fibrosis patients (CF): Which is the best treatment? Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013
Host specificity of pseudomonas aeruginosa isolates from patients with cystic fibrosis and patients from different clinical backgrounds Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014
Temporal progression of fungal microbiota in patients with cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015
Cystic fibrosis Source: Respipedia Article Year: 2018
Emerging pathogens in cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=66 Year: 2006
LATE-BREAKING ABSTRACT: Is there a relationship between use of inhaled antibiotics and prevalence of fungal isolates in the respiratory secretions of people with cystic fibrosis? A retrospective data analysis Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015
Does the cystic fibrosis phlegm feed the pseudomonas? Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016
Efficacy and safety of inhaled antibiotics for chronic pseudomonas infection in cystic fibrosis: Network meta-analysis Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016
Cystic fibrosis: Achromobacter xylosoxidans colonized patients have more severe respiratory disease Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
Cystic fibrosis patients have different microbiological colonization comparing to other bronchiectasis Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010
Microevolution of pseudomonas aeruginosa in cystic fibrosis lungs Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014
Bacterial infection and lung function in patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 615s Year: 2005
Applicative value of chest HRCT for bronchiectasis evaluating in pulmonary infection with pseudomonas aeruginosa in patients with cystic fibrosis Source: International Congress 2016 – Mixed-up imaging of various chest diseases Year: 2016
Clinical value of lung clearance index (LCI) among patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014
Resistance to antimicrobial agents in patients with non-cystic fibrosis (CF) bronchiectasis Source: Eur Respir J 2005; 26: Suppl. 49, 640s Year: 2005
Frequency and pathogenicity of rhinovirus associated pulmonary exacerbations in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013
Adaptation of prevotella during acute infectious pulmonary exacerbation Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014
Inhaled colistin in patients with non - cystic fibrosis bronchiectasis and chronic pseudomonas aeruginosa bronquial infection Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016
Epidemiology of new pathogens in a cohort of patients with cystic fibrosis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008